Vanda Pharmaceuticals
VNDA
#8442
Rank
โ‚ฌ0.26 B
Marketcap
4,46ย โ‚ฌ
Share price
0.39%
Change (1 day)
16.79%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -โ‚ฌ0.14 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2025 the company made an earning of -โ‚ฌ0.14 Billion a decrease over its 2024 earnings that were of -โ‚ฌ35.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.14 Billion4.18%
2025 -โ‚ฌ0.14 Billion271.79%
2024 -โ‚ฌ35.39 Million191.43%
2023 -โ‚ฌ12.15 Million-320.45%
2022 โ‚ฌ5.5 M-84.99%
2021 โ‚ฌ36.69 M54.8%
2020 โ‚ฌ23.7 M19.42%
2019 โ‚ฌ19.85 M4.93%
2018 โ‚ฌ18.91 M-228.6%
2017 -โ‚ฌ14.72 Million-8.98%
2016 -โ‚ฌ16.17 Million-53.79%
2015 -โ‚ฌ34.98 Million-30.18%
2014 -โ‚ฌ50.1 Million173.08%
2013 -โ‚ฌ18.35 Million-25.33%
2012 -โ‚ฌ24.57 Million163.61%
2011 -โ‚ฌ9.32 Million-221.15%
2010 โ‚ฌ7.69 M-124.53%
2009 -โ‚ฌ31.36 Million-29.44%
2008 -โ‚ฌ44.45 Million-36.2%
2007 -โ‚ฌ69.66 Million21.81%
2006 -โ‚ฌ57.19 Million170.55%
2005 -โ‚ฌ21.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.60 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.73 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.21 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ27.08 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.44 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.35 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.45 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA